Fermentation-Derived Monk Fruit & Rare Sweetener Market

How big is the Fermentation-Derived Monk Fruit & Rare Sweetener Market in 2026?

USD 645.2 million in 2026 and USD 2,391.9 million by 2036 at a 14.0% CAGR.

Sales of fermentation-derived monk fruit and rare sweeteners are projected to expand at a 14.0% CAGR between 2026 and 2036. The industry valuation is forecast to rise from USD 645.2 million in 2026 to USD 2391.9 million by 2036. In September 2025, Cargill reported regulatory approvals for EverSweet across four major food markets worldwide. The announcement also confirmed adoption by major food and beverage brands that already use the precision-fermented stevia ingredient. Regulatory access and customer use must develop together for a new molecule to support recurring commercial programs. Commercial momentum for precision fermentation ingredients depends on consistent production and practical application support across each intended launch market.

International commercialization depends on route-specific approvals and complete technical files for each intended food category and production organism. In April 2025, the European Commission authorized steviol glycosides produced through Yarrowia lipolytica fermentation under Regulation (EU) 2025/652. The regulation defines permitted food categories and use conditions for E 960b throughout the European Union. Comparable rare sugar approvals remain national decisions and cannot transfer automatically across jurisdictions with different additive systems. Food manufacturers therefore need local labeling guidance and application testing for formulas planned across several countries. Commercial agreements should assign regulatory documentation and sensory validation to separate technical teams with clear responsibilities.

Key Takeaways of Fermentation-Derived Monk Fruit & Rare Sweetener Market

• Demand for fermentation-derived monk fruit and rare sweeteners is driven by controlled production separating supply from harvest volume and concentrated crop regions, reducing exposure to agricultural timing across long-term ingredient contracts.
• By product, fermented mogroside holds the leading share at 49.4% in 2026, attributable to demand for monk fruit sweetness beyond harvest-dependent extraction.
• Powder is the dominant form segment, holding 47.2% share in 2026, due to measured dosing and efficient storage across concentrated premixes.
• Beverages account for 41.3% application share in 2026, owing to clear sensory and stability testing during pilot production runs.
• Route-specific approvals remain critical to commercialization, determining whether a technically successful ingredient can enter recurring food-manufacturing programs under defined use conditions.
• China, Brazil, and the USA record CAGRs of 15.9%, 15.5%, and 15.1% respectively through 2036, though the narrow forecast range hides major differences in importer capability and technical documentation requirements.
• Competition centers on Manus, Bestzyme, Cargill, Sweegen, Tate & Lyle, and Ingredion, with vendors differentiating through commercial biomanufacturing scale-up, broader taste-system integration, and application laboratory support across regional distribution networks.

Analyst Perspective

The commercial test for fermented mogroside isn't sweetness intensity but whether a manufacturer can rebuild the bulk and browning functions sucrose provides, since high-potency sweeteners lower dose requirements while leaving a functional gap that fibers or polyols have to fill through a separate formulation route entirely. Manus's US-produced monk fruit launch matters less for its purity claims than for what it signals about supply diversification, since traceability beyond one agricultural region changes the risk profile for buyers who previously depended entirely on southern China cultivation. Beverages will likely remain the proving ground for these ingredients precisely because water offers no texture to mask sweetness onset or lingering notes, making it the format where a formulation's real sensory weaknesses surface before a company commits to solid-food applications with more forgiving matrices.

-Nandini Roy Choudhury, Principal Analyst at Future Market Insights

Source: FMI's proprietary forecasting model and primary research

How is the Fermentation-Derived Monk Fruit & Rare Sweetener Market segmented?

The fermentation-derived monk fruit and rare sweetener industry is segmented by product, form, application, and region.

The framework separates ingredient identity from physical handling and final food use across the complete commercialization route. Product analysis covers fermented mogroside and steviol glycosides together with rare sugars under distinct production routes. Form analysis compares powder with liquid formats and granules with paste through storage stability and dosing behavior. Application analysis compares beverages with dairy and bakery products through sweetness quality and texture or processing requirements. Regional analysis examines approval routes and application support across countries that use different food-additive systems. The structure links each molecule with the process that carries it into a finished food product. The comparison also separates regulatory barriers from formulation problems across the wider sweetener formulation market.

What supports demand for fermented mogroside within the product category?

Fermented mogroside gives food manufacturers a second route to sweetness that has historically depended on monk fruit cultivation in southern China. In June 2026, Manus launched the first United States-produced monk fruit sweetener at commercial scale and began supplying formulation samples. The ingredient uses an optimized mogroside profile to support consistent purity and clean sweetness across repeated production batches. The launch diversifies supply for monk fruit ingredients that need traceability beyond one agricultural region.

• The fermented mogroside segment is likely to capture 49.4% share in 2026 attributable to demand for monk fruit sweetness beyond harvest-dependent extraction. The segment gives manufacturers a familiar taste target across monk fruit sugar programs that require stable batch profiles. Its position reflects demand for the specific mogroside rather than interest in fermentation-derived sweeteners as a whole.
• Food manufacturers should test fermented mogroside inside the complete flavor system under expected processing and storage conditions. High sweetness intensity lowers dose requirements but cannot replace the bulk and browning functions that sucrose provides. Fibers or polyols restore body across dairy and bakery formulas through a separate formulation mechanism. Adoption depends on sensory performance and complete regulatory documentation for every intended food category and production route.

How is powder positioned within the form category?

Powder suits dry premixes that require measured dosing and stable storage across concentrated sweetener systems. In April 2026, FDA closed GRN 1296 with no questions for erythritol produced through glucose fermentation by Yarrowia lipolytica. The notice permits sweetening and other formulation functions across specified food categories under FDA-reviewed conditions. The FDA record demonstrates how one fermentation-derived rare sugar can support several technical roles under a controlled specification. Production teams must control powder flow and moisture exposure together with dissolution so dosing remains stable during storage and mixing.

• The form category is forecast to be led by powder at 47.2% share in 2026 due to measured dosing and efficient storage across concentrated premixes. Comparable powdered stevia systems use moisture barriers to preserve flow properties during warehouse storage and repeated plant handling. Sealed packaging reduces agglomeration and dosing variation across routine production shifts and long inventory cycles.
• Plant operators should compare powder flow with dissolution speed and dust control across the intended production line. Humid handling creates agglomeration risks even if the active ingredient remains chemically stable throughout storage. Product specifications should define moisture limits and particle behavior together with packaging protection across storage and production. These controls preserve dosing accuracy during normal warehouse storage and repeated production cycles without disrupting output.

What makes beverages central to the application category?

Beverages reveal sweetness onset and lingering notes more clearly than many solid foods due to limited texture masking in water. In March 2026, Oobli and SIG began joint development of protein-sweetened beverages for aseptic filling and shelf-stable packaging. The program covers beverage concepts and pilot runs together with consumer testing through SIG innovation centers. The partnership gives manufacturers a practical route for testing sweet protein systems across processing and ambient distribution.

• The beverages application is projected to hold 41.3% share in 2026 owing to clear sensory and stability testing during pilot production. Liquid trials expose acidity response and lingering sweetness during controlled runs that precede full commercial filling. Packaging trials also reveal whether the formula needs taste modulation or added bulk during shelf storage.
• Beverage manufacturers should validate the complete formula across processing temperature and the intended commercial shelf life. Acids and flavor systems change the finish of high-intensity ingredients during extended storage and distribution. Commercial acceptance depends on solubility and sensory targets together with stability limits under the actual filling process. Final packaging must preserve those results consistently through normal distribution and extended retail storage conditions.

What are the drivers, restraints, and opportunities in the Fermentation-Derived Monk Fruit & Rare Sweetener Market?

Commercial demand grows through consistent sweetener production and stronger sugar-reduction programs across several food categories. Route-specific approvals limit market entry even as new rare-sugar authorizations create focused formulation openings for qualified manufacturers.

• Driver: Food manufacturers need dependable sweetness and supply across repeated sugar-reduction programs in beverages and dairy or bakery products.
• Restraint: Each production route needs specific safety documentation and permitted-use conditions prior to legal commercial sale in every target country.
• Opportunity: Fermentation widens access to scarce molecules and supports blended systems that restore sweetness together with body and texture.

Food manufacturers are expanding sugar-reduction programs that need clean taste and repeatable supply across several product categories. In February 2025, Ingredion and Oobli formed a partnership that combines Oobli sweet proteins with Ingredion stevia solutions. The companies targeted beverages and other foods through established application support and regional commercial distribution networks. The arrangement gives naturally derived sweeteners a practical route for combining ingredients that address sweetness timing and mouthfeel. A complete system reduces reformulation work without relying on one high-intensity molecule for every sensory function.

Country-specific food rules slow entry by limiting each authorization to defined ingredients and permitted uses within a national system. In July 2025, Anvisa opened a public consultation on maximum levels and technological functions for additives across specific food categories. Brazilian food companies must secure an authorized use for each fermentation-derived ingredient prior to commercial production. Approval in another jurisdiction cannot replace the national safety assessment and labeling requirements for a Brazilian product. The additional work extends launch schedules through route-specific specifications and application files for each intended local use.

New rare-sugar authorizations create a practical opening for fermentation platforms that deliver consistent purity at commercial scale. In July 2025, China authorized D-allulose as a new food raw material and accepted microbial fermentation as a production route. The decision expands allulose applications for manufacturers that meet the stated quality and daily intake conditions. Formulators combine its bulk contribution with high-intensity sweeteners across beverages and other reduced-sugar foods and preserve product body during reformulation. Commercial success depends on production economics and complete local documentation for every finished application in the target country.

Which country CAGRs are profiled in the Fermentation-Derived Monk Fruit & Rare Sweetener Market?

Country	CAGR
USA	15.1%
China	15.9%
Germany	14.7%
Japan	14.3%
Brazil	15.5%

How do country-level CAGRs compare in the Fermentation-Derived Monk Fruit & Rare Sweetener Market?

The forecasts span 1.6 percentage points and therefore show similar momentum without identical national entry conditions. China and Brazil form the upper pair through a narrow 0.4-point separation that offers limited strategic distinction. The USA occupies the midpoint and remains equally distant from Germany within the displayed forecast sequence. Germany and Japan form the lower pair through another 0.4-point interval with different regulatory routes. Commercial planning should prioritize legal access and technical service rather than minor differences between neighboring forecast rates.

• China combines the upper forecast band with a national route that recognizes defined fermentation processes for approved sweetener ingredients. Foreign developers need Chinese technical files and local formulation support for customer trials to progress into routine production.
• Brazil tracks closely beside China but applies positive authorization rules that exclude ingredients accepted in several foreign markets. Regulatory counsel and prepared importers therefore carry greater commercial weight than the narrow forecast difference.
• The United States occupies the midpoint and offers a GRAS notification route for specific production organisms and intended food uses. Food brands also need category-level sensory work so a safety conclusion can support recurring commercial orders.
• Germany follows European Union additive rules and maintains national scrutiny of sweetener exposure across formulated food categories. Beverage manufacturers need permitted-use checks and application evidence designed for local reformulation programs and shelf-life targets.
• Japan closes the displayed range through a food-additive system built around approved specifications and formal use standards. Local importer knowledge and responsive technical service remain necessary for fermentation-derived ingredients entering customer qualification.

Country CAGRs should be assessed beside legal sale status and customer concentration rather than treated as absolute revenue rankings. A country with a narrower rate can support larger contracts through established ingredient groups serving major food manufacturers. The full report provides country-level CAGR analysis across North America and Latin America together with Europe and East Asia. Coverage also includes South Asia and Oceania together with the Middle East and Africa across distinct regional markets.

Country-wise Analysis

• United States food companies can use the GRAS notification route for defined fermentation-derived sweeteners and stated food uses. Fermentation-derived monk fruit and rare sweetener demand in the United States is forecast to rise at a 15.1% CAGR over the forecast period, reinforced by GRAS access and application support. In June 2026, FDA closed GRN 1293 from Sweegen with no questions for a fermentation-produced brazzein preparation used as a general-purpose sweetener. The FDA conclusion gives sweet protein developers a documented legal enabler across several food categories. Each notifier must support the exact production organism and final specifications through a complete technical dossier. Food manufacturers must restore sugar bulk and mouthfeel through application work inside the finished formula. Regional laboratories and established distributors reduce service distance across major United States food-manufacturing regions during customer qualification.
• China combines large fermentation capacity with a national review route for new food ingredients and additive production processes. In November 2025, the National Health Commission authorized fermentation-produced steviol glycosides within food categories already approved for steviol glycosides. The Chinese fermentation-derived monk fruit and rare sweetener sector is projected to record a 15.9% CAGR during the assessment period, driven by domestic fermentation capacity and new ingredient approvals. The authorization creates a direct enabler for companies that meet the stated quality specifications during commercial entry. Commercial friction comes from Chinese technical files and local labeling together with importer coordination during initial qualification. Foreign producers need regional technical staff and qualified distribution partners across long internal service distances. Local fermentation infrastructure shortens supply routes for approved products with completed documentation and application testing across national customers.
• Germany operates under European Union additive authorizations and national monitoring of sweetener exposure across processed foods. In September 2025, the German Federal Institute for Risk Assessment reported lower sugar content in soft drinks and greater use of drinks sweetened exclusively with sweeteners. The findings support active beverage reformulation but do not remove product-specific taste and exposure reviews. Germany's fermentation-derived monk fruit and rare sweetener outlook is anticipated to advance at a 14.7% CAGR over the assessment period, supported by established beverage manufacturing and application laboratories. Commercial friction includes permitted-use checks and sensory differences across several beverage categories during customer qualification. German application laboratories provide a direct enabler through acidity and flavor testing together with commercial shelf-life work. Commercial agreements should assign compliance records and sensory corrections to named regulatory and formulation specialists.
• Japan uses a positive food-additive system that combines safety review with detailed specifications and formal use standards. Adoption of fermentation-derived monk fruit and rare sweetener in Japan is estimated to expand at a 14.3% CAGR through 2036, linked to precise formulation practices and formal food-additive specifications. Local importer knowledge and complete production records help developers navigate national review and customer qualification requirements. In February 2025, the Consumer Affairs Agency added an English version of the tenth food-additive compendium covering composition and manufacturing together with use and labeling standards. Commercial friction includes Japanese specifications and application testing across each intended food category during qualification. Producers need local partners that resolve technical questions without delaying importer decisions or customer trials. Service coverage around major food-manufacturing clusters improves qualification support during initial commercial programs and product trials.
• Brazil applies a positive authorization system for food additives and requires safety evaluation for ingredients without local use history. In December 2025, Anvisa stated that allulose was not authorized as a sweetener or food ingredient and prohibited an affected product. Fermentation-derived monk fruit and rare sweetener sales in Brazil are forecast to expand at a 15.5% CAGR by 2036, shaped by beverage reformulation and strict local authorization. The action prevents companies from transferring foreign approvals into Brazil without a complete local review. Established beverage manufacturers and regional distributors create a direct enabler for ingredients that secure national authorization. Import documentation and application support remain material commercial frictions during customer qualification and initial production. Market entry requires regulatory counsel and dependable technical service across regional food-manufacturing programs and customer trials.

Who are the notable companies in the Fermentation-Derived Monk Fruit & Rare Sweetener Market?

Manus, Cargill, Tate & Lyle, Sweegen, Bestzyme, Oobli, Ingredion, and Amai Proteins are the notable companies shaping this market.

The competitive field combines fermentation developers with ingredient groups that scale supply and solve formulation problems across several food categories. In February 2026, Manus opened a purpose-built Singapore application hub for customers throughout the Asia-Pacific region. The hub provides hands-on formulation testing and regional technical service for sweeteners and other complex ingredients. The expansion demonstrates that commercial reach depends on application capability alongside molecule production and manufacturing scale. Comparable sugar substitute portfolios compete through regulatory files and taste systems together with dependable logistics. Specialists differentiate through novel molecules; larger ingredient groups reduce qualification risk through established distribution and application laboratories.

• Manus and Bestzyme develop fermentation platforms for mogrosides and sweet proteins across commercial production programs. Oobli and Amai Proteins focus on designed sweet proteins that require regulatory files and application testing. In July 2026, Bestzyme presented Mellia® beverage and confectionery prototypes during IFT FIRST in Chicago. Competition across this group centers on repeatable batch quality and route-specific files together with sensory performance.
• Cargill and Sweegen combine fermentation-derived sweeteners with broader taste systems and established commercial supply networks. Their scale supports multi-country programs that require dependable delivery and consistent application results across several food categories. Competition in this group centers on supply continuity and documentation together with control of off-notes during sugar reduction.
• Tate & Lyle and Ingredion connect emerging molecules with formulation laboratories and regional commercial networks across major food markets. Their application scientists test sweetness timing and mouthfeel together with stability across beverages and other foods. Their advantage comes from shorter reformulation cycles with use-specific documentation and production-route records retained for each program.

Competitive Benchmarking: Fermentation-Derived Monk Fruit & Rare Sweetener Market

Company	Fermentation Portfolio	Scale and Supply	Formulation Support	Geographic Reach
Manus	High	High	High	North America and Asia-Pacific
Cargill	Medium	High	High	Global
Tate & Lyle	Medium	Medium	High	Global
Sweegen	High	Medium	High	Global
Bestzyme	Medium	Medium	High	China and international customer programs
Oobli	High	Medium	High	United States and Andean partner markets
Ingredion	Medium	Low	High	Global
Amai Proteins	Medium	Low	Medium	Israel and United States

Key Developments in the Fermentation-Derived Monk Fruit & Rare Sweetener Market

• In February 2026, Manus and Tate & Lyle launched Yume™ under The Sweetener Alliance for commercial sugar-reduction programs. Manus produces Yume™ M Stevia at its Augusta biomanufacturing facility and Tate & Lyle provides formulation expertise with market access. The launch creates a regional stevia supply route with traceability from production through food and beverage application work. Regional production shortens supply lines and improves response times during formulation scale-up across North and South American programs.
• In February 2026, Amai Proteins received FDA closure of GRN 1269 with no questions for sweelin® as a general-purpose sweetener. The precision-fermented monellin preparation gained a defined United States route for product trials and commercial discussions with food manufacturers. The milestone adds another sweet protein family to the available sugar-reduction toolkit across several food categories. Each manufacturer must complete application testing for the intended beverage or food system during commercial qualification.
• In April 2026, Oobli and Magdalena's Biochem Unit formed an Andean manufacturing and development hub for commercial sweet proteins. The partnership combines Oobli's fermentation processes with Magdalena's industrial infrastructure and regional sugar-based feedstock for commercial production. Regional manufacturing shortens delivery routes and supports local regulatory work across Central and South American markets. The hub gives sweet protein programs a clearer path from formulation trials to scaled regional supply.
• In April 2025, Bestzyme received FDA closure of GRN 1207 with no questions for a fermentation-produced brazzein preparation. The regulator record establishes a defined United States route for use as a general-purpose sweetener under stated conditions. The milestone strengthens Bestzyme's commercial position across beverage and confectionery programs requiring clean sweetness at low use levels. Food manufacturers must confirm taste and stability inside each finished formula during customer qualification work.

Key Players in the Fermentation-Derived Monk Fruit & Rare Sweetener Market

Biomanufacturing and Molecule Developers

• Manus
• Bestzyme
• Oobli
• Amai Proteins

Scaled Sweetener Manufacturers

• Cargill
• Sweegen

Formulation and Commercialization Specialists

• Tate & Lyle
• Ingredion

Fermentation-Derived Monk Fruit & Rare Sweetener Market - Report Scope

Coverage field	Report scope
Market breakdown	Product, form, application, and region.
Quantitative Units	Revenue in USD Million, CAGR in %.
Market Definition	Revenue from fermentation-derived monk fruit sweeteners and fermentation-produced rare sugars or sweet proteins sold for food and beverage use. The scope includes ingredient supply and directly related commercial services but excludes conventional crop extraction without a fermentation step.
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
Countries Covered	USA, China, Germany, Japan, Brazil, plus more than twenty-five additional countries across the regions covered.
Key Companies Profiled	Manus, Cargill, Tate & Lyle, Sweegen, Bestzyme, Oobli, Ingredion, and Amai Proteins
Forecast Period	2026 to 2036.
Approach	Hybrid bottom-up and top-down market sizing supported by primary interviews and authoritative desk research.

Fermentation-Derived Monk Fruit & Rare Sweetener Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Fermentation-Derived Monk Fruit & Rare Sweetener Market by Segments

Fermentation-Derived Monk Fruit & Rare Sweetener Market segmented by Product:

• Fermented Mogroside
• Steviol Glycosides
• Rare Sugars

Fermentation-Derived Monk Fruit & Rare Sweetener Market segmented by Form:

• Powder
• Liquid
• Granules
• Paste

Fermentation-Derived Monk Fruit & Rare Sweetener Market segmented by Application:

• Beverages
• Dairy
• Bakery

Fermentation-Derived Monk Fruit & Rare Sweetener Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• Agência Nacional de Vigilância Sanitária. (2025, July 9). Anvisa abre consulta pública sobre aditivos e coadjuvantes alimentares.
• Agência Nacional de Vigilância Sanitária. (2025, December 22). Anvisa proíbe alimento com ingrediente não autorizado.
• Bundesinstitut für Risikobewertung. (2025, September 26). Health risk assessment of the use of sweeteners in soft drinks.
• Cargill. (2025, September 26). Cargill’s EverSweet® stevia sweetener named a finalist in the 2025 Global Good Awards Game Changing Innovation of the Year.
• Consumer Affairs Agency. (2025, February 5). 第10版食品添加物公定書.
• Bestzyme. (2026, July 16). Successful Conclusion at IFT FIRST 2026 | Bestzyme's Mellia® Sweet Protein Reshapes the Global Sugar Reduction Trend.
• European Commission. (2025, April 2). Commission Regulation (EU) 2025/652 of 2 April 2025 amending Regulation (EC) No 1333/2008 of the European Parliament and the Council and Commission Regulation (EU) No 231/2012 as regards the use of Steviol glycosides produced by fermentation using Yarrowia lipolytica.
• USA Food and Drug Administration. (2025, April 10). GRN No. 1207: Brazzein preparation produced by Aspergillus oryzae 90402 expressing a gene encoding for brazzein from Pentadiplandra brazzeana.
• USA Food and Drug Administration. (2026, June 23). GRN No. 1293: Brazzein preparation produced by Komagataella phaffii RA-b expressing a gene encoding for brazzein from Pentadiplandra brazzeana.
• USA Food and Drug Administration. (2026, April 7). GRN No. 1296: Erythritol produced through fermentation of glucose by Yarrowia lipolytica.
• Ingredion. (2025, February 28). Ingredion y Oobli anuncian alianza ante la creciente demanda de proteínas dulces.
• Manus. (2026, February 5). Manus opens a purpose-built application hub in Singapore to serve Asia-Pacific.
• Manus. (2026, June 18). Made in America: Manus unveils the first monk fruit sweetener produced in the USA at commercial scale.
• National Health Commission of the People’s Republic of China. (2025, July 2). 解读《关于D-阿洛酮糖等20种“三新食品”的公告》（2025年第4号）.
• National Health Commission of the People’s Republic of China. (2025, November 27). 解读《关于威尼斯镰刀菌蛋白等14种“三新食品”的公告》（2025年第7号）.
• Oobli. (2026, March 18). SIG and Oobli Announce Strategic Partnership to Advance Protein-Sweetened Beverages in Aseptic Packaging Solutions.
• Oobli. (2026, April 15). Oobli Sweet Proteins Announces Andean Regional Manufacturing Partnership with Magdalena's New Biochem Unit.
• USA Food and Drug Administration. (2026, February 4). GRN No. 1269: Monellin preparation produced by Komagataella phaffii CBS 150005 expressing a gene encoding for a modified monellin.
• Tate & Lyle. (2026, February 23). Introducing Yume™: A new standard for sweetness.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• How large is the fermentation-derived monk fruit and rare sweetener market in 2026 and 2036?
• Which regulatory developments support commercial use of fermentation-derived sweeteners across major markets?
• Why does fermented mogroside account for a prominent product share in 2026?
• How does powder support handling and qualification across concentrated sweetener systems?
• Why do beverages account for a prominent application share in 2026?
• How do country growth rates differ across China, Brazil, the USA, Germany, and Japan?
• Which companies develop molecules or supply fermentation-derived sweetener systems?
• What limits commercialization across different regulatory and formulation environments?
• How should manufacturers compare scale with sensory performance and technical support?